🧮
home/
calculators/
health/
ascvd risk calculator

ASCVD Risk Calculator – 10‑Year Heart Disease & Stroke Risk (ACC/AHA)

Loading...

The ASCVD Risk Calculator estimates the 10‑year risk of a first hard atherosclerotic cardiovascular disease (ASCVD) event – heart attack, stroke, or coronary death – using the Pooled Cohort Equations endorsed by the American College of Cardiology (ACC) and American Heart Association (AHA). This tool is essential for primary prevention, helping clinicians and patients decide on statin therapy, blood pressure targets, and lifestyle modifications. The calculator is validated for adults aged 40‑79 years without known ASCVD.

ASCVD Risk CategoriesLow: <5%Borderline: 5‑7.4%Intermediate: 7.5‑19.9%High: ≥20%10‑year risk of heart attack or stroke

ASCVD Risk Categories & Management

Low (<5%): Lifestyle modification; no statin generally indicated.

Borderline (5‑7.4%): Consider statin if risk enhancers present (e.g., family history, LDL ≥160).

Intermediate (7.5‑19.9%): Moderate‑intensity statin is recommended. Consider CAC scoring for refinement.

High (≥20%): High‑intensity statin indicated. Aggressive blood pressure control (target <130/80).

How to Use This ASCVD Risk Calculator

  1. Enter age (40‑79), gender, and race.
  2. Provide total cholesterol and HDL (mg/dL).
  3. Enter systolic and diastolic blood pressure.
  4. Indicate if on blood pressure medication, have diabetes, or are a current smoker.
  5. The risk is calculated automatically as you type.

Why ASCVD Risk Assessment Saves Lives

  • Precision prevention: Targets statin therapy to those who benefit most.
  • Shared decision‑making: Visualising risk helps patients understand the need for medication.
  • Guideline‑based: The 2018 ACC/AHA cholesterol guidelines recommend risk assessment before starting statins.
  • Public health: Accurate risk estimation reduces unnecessary medication and prevents events.
Understanding the Pooled Cohort Equations

The Pooled Cohort Equations were derived from multiple community‑based cohorts (ARIC, CARDIA, CHS, FHS). They include traditional risk factors and separate models by gender and race (white/African American). The equations have been validated in external populations, though they may overestimate risk in some contemporary cohorts.

ASCVD Risk Stratification & Clinical Guideline Table

Risk Stratification10-Year Event ProbabilityACC/AHA Clinical Recommendation
Low Risk< 5.0%Lifestyle modifications (diet, physical activity). Reassess in 4–6 years.
Borderline Risk5.0% – 7.4%Risk discussion. Consider moderate-intensity statin if risk enhancers present.
Intermediate Risk7.5% – 19.9%Moderate-intensity statin recommended (e.g. Atorvastatin 10–20mg). Consider CAC score if decision uncertain.
High Risk≥ 20.0%High-intensity statin indicated (e.g. Atorvastatin 40–80mg, Rosuvastatin 20–40mg). Target BP <130/80.

Understanding the Pooled Cohort Equations

The Pooled Cohort Equations were derived from multiple community‑based cohorts (ARIC, CARDIA, CHS, FHS). They include traditional risk factors and separate models by gender and race (white/African American). The equations have been validated in external populations, though they may overestimate risk in some contemporary cohorts. For patients with very high risk (e.g., familial hypercholesterolemia, diabetes with multiple risk factors), clinical judgment may override the score.

Limitations: The calculator does not account for family history of premature ASCVD, chronic kidney disease, inflammatory conditions, or biomarker risk enhancers (e.g., high lipoprotein(a), C‑reactive protein). For patients in the borderline to intermediate risk categories, these risk enhancers can sway the decision to treat. Also, the calculator is not validated for people with established ASCVD – they are already at high risk.

Using the result: For patients with risk ≥7.5%, a moderate‑intensity statin is usually recommended. Those with risk ≥20% should receive high‑intensity statin. Blood pressure goal should be ≤130/80 mmHg. Diabetes patients with a 10‑year risk ≥10% should be on statin. Always discuss potential side effects, and consider a coronary artery calcium (CAC) score if risk classification is uncertain.

Bookmark this ASCVD risk estimator for clinical use. It is a free, evidence‑based tool for healthcare professionals. For personalised treatment, always combine with clinical judgment and patient preferences.

Step‑by‑Step Manual Example

Patient: 55‑year‑old white male, total cholesterol 200, HDL 50, BP 120/80, non‑smoker, no diabetes, not on BP treatment

Using published coefficients, the risk is ~3.2% → Low risk.

Frequently Asked Questions about ASCVD Risk

What is ASCVD?
Atherosclerotic cardiovascular disease (ASCVD) includes heart attack, stroke, peripheral arterial disease, and coronary death. The ASCVD risk score estimates the 10‑year probability of having one of these events.
Who should use this calculator?
It is intended for adults aged 40‑79 years without known ASCVD. For younger or older individuals, or those with established heart disease, different risk assessment tools apply.
How accurate is the ASCVD risk score?
The Pooled Cohort Equations have been validated in large populations, but they may overestimate risk in some cohorts (e.g., higher‑socioeconomic status). It remains the standard for primary prevention.
What should I do if my risk is high?
Consult your doctor. High‑intensity statin therapy, blood pressure control, smoking cessation, and lifestyle changes are typically recommended.
What are the 4 ASCVD risk categories?
Low Risk (<5%), Borderline Risk (5% to 7.4%), Intermediate Risk (7.5% to 19.9%), and High Risk (≥20%).
When is statin therapy recommended based on ASCVD score?
According to 2018 ACC/AHA Guidelines, statin therapy is generally recommended for intermediate (≥7.5%) and high (≥20%) risk groups, and considered for borderline risk (5-7.4%) with risk-enhancing factors.
What are ASCVD risk enhancers?
Risk enhancers include family history of premature ASCVD, persistent LDL ≥160 mg/dL, chronic kidney disease, metabolic syndrome, preeclampsia, inflammatory diseases (RA, psoriasis), and elevated Lp(a) or hs-CRP.
What is a Coronary Artery Calcium (CAC) score?
CAC scoring uses a heart CT scan to measure calcified plaque. A CAC score of 0 can help withhold or delay statin therapy in intermediate-risk adults without diabetes or heavy smoking history.